Biopharmaceutical Industry
Novartis plans to axe 680 employees
The current downsizing is separate from a company restructuring programme, which could see the dismissal of up to 8,000 employees.
The current downsizing is separate from a company restructuring programme, which could see the dismissal of up to 8,000 employees.